LPL Financial’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,150
| Closed | -$8.88K | – | 5472 |
|
|
2025
Q1 | $8.88K | Buy |
16,150
+128
| +0.8% | +$70 | ﹤0.01% | 5184 |
|
|
2024
Q4 | $14.6K | Sell |
16,022
-4,500
| -22% | -$4.11K | ﹤0.01% | 5105 |
|
|
2024
Q3 | $17.9K | Buy |
20,522
+13
| +0.1% | +$11 | ﹤0.01% | 4988 |
|
|
2024
Q2 | $20.3K | Buy |
20,509
+2,500
| +14% | +$2.48K | ﹤0.01% | 4832 |
|
|
2024
Q1 | $19.1K | Sell |
18,009
-1,570
| -8% | -$1.66K | ﹤0.01% | 4771 |
|
|
2023
Q4 | $26.4K | Sell |
19,579
-2,000
| -9% | -$2.7K | ﹤0.01% | 4650 |
|
|
2023
Q3 | $47K | Buy |
+21,579
| New | +$47K | ﹤0.01% | 4467 |
|
|
2022
Q4 | – | Sell |
-16,512
| Closed | -$20K | – | 4495 |
|
|
2022
Q3 | $20K | Hold |
16,512
| – | – | ﹤0.01% | 4293 |
|
|
2022
Q2 | $17K | Sell |
16,512
-5,000
| -23% | -$5.15K | ﹤0.01% | 4321 |
|
|
2022
Q1 | $34K | Buy |
21,512
+1,000
| +5% | +$1.58K | ﹤0.01% | 4069 |
|
|
2021
Q4 | $29K | Buy |
20,512
+23
| +0.1% | +$33 | ﹤0.01% | 4259 |
|
|
2021
Q3 | $43K | Buy |
20,489
+8,529
| +71% | +$17.9K | ﹤0.01% | 4211 |
|
|
2021
Q2 | $33K | Sell |
11,960
-550
| -4% | -$1.52K | ﹤0.01% | 4149 |
|
|
2021
Q1 | $48K | Buy |
12,510
+1,000
| +9% | +$3.84K | ﹤0.01% | 3972 |
|
|
2020
Q4 | $27K | Sell |
11,510
-2,000
| -15% | -$4.69K | ﹤0.01% | 3751 |
|
|
2020
Q3 | $23K | Hold |
13,510
| – | – | ﹤0.01% | 3477 |
|
|
2020
Q2 | $25K | Buy |
+13,510
| New | +$25K | ﹤0.01% | 3368 |
|